Parkinson’s Disease Biomarkers Market

The global Parkinson’s disease biomarkers market is witnessing substantial growth due to increasing prevalence of neurodegenerative disorders, rising demand for early diagnosis, advancements in precision medicine, and innovations in biomarker-based testing technologies. Companies operating in this market are heavily investing in neurodiagnostics, AI-powered biomarker discovery, imaging solutions, and molecular testing platforms to strengthen their market